Contact Us

About ROSEAId

Established in 2020, ROSEAId emerged from a significant collaboration with the University of Texas Health. ROSEAId is an AI-powered, cloud-based platform designed to support pathology image assessment, collaborative review, specimen adequacy evaluation workflows, and research initiatives across academic and laboratory environments.

ROSEAId provides digital tools that support pathology image review, collaboration, and workflow management across distributed teams. The platform enables secure collaboration, digital case sharing, and efficient management of pathology image data. Essentially, creating a limitless pathology workspace, allowing pathologists to capture, share, and review pathology image information efficiently regardless of location.
With advanced Machine Learning algorithms and Multi-Modal Large Language Model (MMLLM) technologies, ROSEAId supports the organization, analysis, and retrieval of pathology image data and related research information. These capabilities are designed to streamline data exploration, research workflows, and laboratory documentation.
We are dedicated to transforming complex datasets into actionable research insights, supporting scientific discovery and innovation throughout the healthcare ecosystem.

What Makes Us Different

The Values We Live By

Mission

ROSEAId fulfills the specialized requirements of pathologists through advanced data analytics and streamlined workflow tools, providing real-time image assessment insights and laboratory workflow support.

Vision

To establish a future standard in telepathology focused on pathology image assessment, collaborative review, and workflow efficiency, with future clinical applications subject to applicable regulatory clearances.

People

Our people's compassion and commitment to achieving better outcomes set them apart, driving a culture of empathy and dedication that fuels our collective pursuit of excellence and impact.

ROSEAId Leaders

Joseph
Rossi

CEO & Board Member
Linkedin

Camille
Beyrouthy, PhD

CFO & Board Member
Linkedin

Dr. Efrat
Eliyahu

Chief Science Officer &
Board Member
Linkedin

Eli
Zukovsky

CTO, Co Founder &
Board Member
Linkedin

Russell
Raff

CPO, Co Founder &
Board Member
Linkedin

Barak
Tsivkin

Board Member
Linkedin

Harvey E.
Rand

Chief Revenue Officer
Linkedin

Baxter
Garcia, PhD

Chief Biomedical Engineer
Linkedin

ROSEAId Science and Medical Advisory Board

Dr. Nirav C. Thosani

University of Texas

Dr. Songlin Zhang

Baylor University

Natasha Shtraizent

Frezent

Dr. Yosep Chong

The Catholic University of
Korea Medical Director

Dr. Richard Newman

Telespecialists LLC.

Baxter
Garcia, PhD

Chief Biomedical Engineer
Linkedin

ROSEAId Sales Distributors

Farouk Khailann

Senior Market Advisor Middle East, Africa

Paul Cucurullo

STIGroup Limited LLC

Rick Yi

STSC Global Asia

Wendy Cowan

StrongHer Consulting LLC Caribbean, Latin America, Africa

Contact us

  • in**@*****id.com

Regulatory Notice: Certain ROSEAId platform features and AI-enabled technologies are investigational and may be intended for research use only. These features have not been cleared or approved by the U.S. Food and Drug Administration for diagnostic use.

Our Offices

Houston (Representative)

  • 5868 Westheimer Rd Suite 505 Houston, TX 77057

New York (Headquarters)

  • 200 E. Erie Street, Suite 2S, Blauvelt, NY 10913

Abu Dhabi (Representative)

  • 7th Floor, Ci Tower
    Al Bateen, Abu Dhabi